A detailed history of Cornercap Investment Counsel Inc transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 11,791 shares of CCCC stock, worth $42,447. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,791
Previous 27,136 56.55%
Holding current value
$42,447
Previous $125,000 46.4%
% of portfolio
0.02%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$4.43 - $7.38 $67,978 - $113,246
-15,345 Reduced 56.55%
11,791 $67,000
Q2 2024

Aug 08, 2024

BUY
$4.05 - $8.1 $109,900 - $219,801
27,136 New
27,136 $125,000
Q4 2023

Jan 30, 2024

SELL
$1.18 - $6.03 $1,380 - $7,055
-1,170 Reduced 2.47%
46,286 $261,000
Q3 2023

Nov 13, 2023

SELL
$1.81 - $3.89 $1,069 - $2,298
-591 Reduced 1.23%
47,456 $88,000
Q1 2023

May 11, 2023

BUY
$3.1 - $9.02 $67,443 - $196,239
21,756 Added 82.75%
48,047 $150,000
Q4 2022

Feb 13, 2023

BUY
$5.42 - $10.24 $25,419 - $48,025
4,690 Added 21.71%
26,291 $155,000
Q3 2022

Nov 14, 2022

BUY
$8.03 - $12.77 $9,660 - $15,362
1,203 Added 5.9%
21,601 $189,000
Q2 2022

Aug 15, 2022

BUY
$5.06 - $26.46 $103,213 - $539,731
20,398 New
20,398 $154,000

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $176M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.